Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Sep 30, 2025 | (FY)Sep 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (FY)Sep 30, 2022 | (FY)Sep 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 25.41%1.9B | 10.67%1.52B | 377.42M | 335.76M | 86.78%1.37B | 349.12M | 382.4M | 11.63%733.05M | 656.66M |
| Cost of revenue | 25.83%628.24M | 3.79%499.28M | 128.92M | 110.78M | 121.25%481.07M | 124.43M | 142.69M | 17.47%217.44M | 185.09M |
| Gross profit | 25.21%1.27B | 14.40%1.02B | 248.5M | 224.98M | 72.25%888.12M | 224.69M | 239.71M | 9.34%515.61M | 471.57M |
| Operating expense | 29.80%1.08B | 22.11%832.59M | 200.18M | 205.86M | 19.48%681.84M | 185.63M | 174.33M | 46.95%570.66M | 388.34M |
| Operating profit | 4.39%191.44M | -11.09%183.39M | 48.33M | 19.12M | 474.74%206.27M | 39.06M | 65.38M | -166.14%-55.04M | 83.23M |
| Net non-operating interest income (expenses) | 1,406.11%2.71M | 204.65%180K | 41.69%-172K | -20K | -46K | 27.52%-295K | -407K | ||
| Non-operating interest income | 1,416.11%2.73M | 1,185.71%180K | ---- | ---- | 600.00%14K | --6K | --3K | 100.00%2K | --1K |
| Non-operating interest expense | --18K | --0 | ---- | ---- | -37.37%186K | --26K | --49K | -27.21%297K | --408K |
| Net investment income | -50.00%-489K | -129K | -187K | -64.65%-326K | 94K | -37K | 41.76%-198K | -340K | |
| Gain(Loss) on financial instruments designated as cash flow hedges | |||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | |||||||||
| Income from associates and other participating interests | -28.05M | ||||||||
| Special income (charges) | 48.92M | -295K | |||||||
| Less:Other special charges | ---48.92M | ---- | ---- | ---- | ---- | ---- | ---- | --295K | ---- |
| Other non-operating income (expenses) | -64.55%145K | 103.46%409K | 111K | 11K | -7,678.21%-11.82M | -9.18M | -2.88M | -91.95%156K | 1.94M |
| Income before tax | 17.26%215.17M | -5.39%183.49M | 48.32M | 18.95M | 448.35%193.95M | 29.96M | 62.42M | -165.95%-55.68M | 84.42M |
| Income tax | 36.99%68.36M | -8.26%49.9M | 15.49M | 6.53M | 443.63%54.4M | 2.08M | 19.77M | -166.59%-15.83M | 23.77M |
| Net income | 9.89%146.8M | -4.28%133.59M | 32.83M | 12.42M | 450.23%139.55M | 27.88M | 42.65M | -165.70%-39.85M | 60.65M |
| Net income continuous operations | 9.89%146.8M | -4.28%133.59M | --32.83M | --12.42M | 450.23%139.55M | --27.88M | --42.65M | -165.70%-39.85M | --60.65M |
| Noncontrolling interests | |||||||||
| Net income attributable to the company | 9.89%146.8M | -4.28%133.59M | 32.83M | 12.42M | 450.23%139.55M | 27.88M | 42.65M | -165.70%-39.85M | 60.65M |
| Preferred stock dividends | |||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 9.89%146.8M | -4.28%133.59M | 32.83M | 12.42M | 450.23%139.55M | 27.88M | 42.65M | -165.70%-39.85M | 60.65M |
| Gross dividend payment | |||||||||
| Basic earnings per share | 9.49%9.23 | -13.09%8.43 | 2.08 | 0.78 | 393.38%9.7 | 1.7675 | 3.0294 | -186.34%-3.3063 | 3.8292 |
| Diluted earnings per share | 10.09%9.06 | -12.54%8.23 | 2.0719 | 0.78 | 384.61%9.41 | 1.7603 | 2.6928 | -186.34%-3.3063 | 3.8292 |
| Dividend per share | |||||||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |